Head to head
Fortinet vs Microsoft
Side-by-side on the measures that matter, with a plain-English read. Full detail: FTNT · MSFT
FTNT
Fortinet
189.37+0.05%
1-year price shape — +123% over the period
Quant Rating B · 95/100
vs
MSFT
Microsoft
531.10+0.25%
1-year price shape — +2% over the period
Quant Rating C · 40/100
1-year performance, rebased to 100
Microsoft edges it on the scoreable measures. Microsoft trades cheapest on trailing earnings; Microsoft pays the highest dividend yield; Microsoft earns the most per share.
| FTNT | MSFT | |
|---|---|---|
| Snapshot | ||
| Sector | Software - Infrastructure | Software - Infrastructure |
| Last price | 189.37 | 531.10 |
| Change today | +0.05% | +0.25% |
| 1-year return | +122.9% | +1.9% |
| Market cap | $138.94B | $3.94T |
| 52-week range | 73.55 – 192.41 | 348.54 – 549.20 |
| Valuation | ||
| P/E (TTM) | 66.92 | 29.59 |
| P/E percentile, own 5-yr range | 81st | 30th |
| P/B | 89.58 | 8.91 |
| Dividend yield | 0.00% | 0.67% |
| Profitability & growth | ||
| EPS (TTM) | 2.42 | 17.95 |
| Net profit (TTM) | $1.78B | $133.29B |
| Revenue (TTM) | $7.53B | $331.84B |
| Revenue growth (YoY) | +25.6% | +17.7% |
| Gross margin | 80.2% | 67.9% |
| Operating margin | 32.4% | 46.8% |
| Net margin | 28.2% | 40.3% |
| Free cash flow (TTM) | $3.12B | $66.99B |
| Ownership & sentiment | ||
| Institutional ownership | 71.1% | 75.3% |
| Insider activity (12mo) | 26 buy / 24 sell | 31 buy / 16 sell |
| Short interest (% of float) | 1.9% | 0.9% |
| Analyst consensus | 23% buy / 65% hold / 12% sell (26) | 100% buy (32) |
| Analyst price target | $177 (-7%) | $582 (+10%) |
| StockVane view | ||
| StockVane Quant Rating | B (95) | C (40) |
| Company | ||
| Employees | 15,109 | 223,000 |
| Founded | 2000 | 1975 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.